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Abstract
BACKGROUND: The device-related infections and erosion of the surgical wound site are special circumstances 
among complications of deep brain stimulation (DBS).
AIM: We aimed to discuss different aspects of hardware infections and contribute to the literature by presenting our 
treatment methods on four patients.
MATERIAL AND METHODS: This study was carried out in the Department of Neurosurgery, School of Medicine 
Hospital, Dokuz Eylul University. Four DBS cases were included in the study, and a retrospective study was performed.
RESULTS: Electrode placement to bilateral subthalamic nuclei was performed due to Parkinson’s Disease to all four 
patients. One of the patients was undergone surgical wound site revision 6 times and device removal at last due to 
device-related infection and erosion of the surgical wound site. The second patient was undergone surgical wound 
site revision for 2 times and device removal at last due to device-related infection and erosion of the surgical wound 
site. The third patient had a collection subcutaneously, where the pulse generator was placed. The collection was 
aspirated. The fourth patient was undergone surgical wound site revision and device removal at last due to device-
related infection and erosion of the surgical wound site. All four patients were given IV antibiotics.
CONCLUSION: For the treatment of DBS device-related infections, a long-term IV antibiotherapy is a suitable option 
before the decision of device removal.
Edited by: Mirko Spiroski
Citation: Kaptan H, Yuzbasi F, Özturk F, Vayvada H. Deep 
Brain Stimulation Hardware Infections: A Case Series. 
Open Access Maced J Med Sci. 2020 Sep 15; 8(C):172-176. 
https://doi.org/10.3889/oamjms.2020.5530
Keywords: DBS; infections; device; surgery; STN
*Correspondence: Hulagu Kaptan. Dokuz Eylül 
University, Department of Neurosurgery, Izmir, Turkey. 
E-mail: hulagukaptan@yahoo.com
Received: 15-Jan-2020
Revised: 20-Jan-2020
Accepted: 21-Feb-2020
Copyright: © 2020 Hulagu Kaptan, Furkan Yuzbasi, 
Fatih Özturk, Haluk Vayvada
Funding: This research did not receive any financial 
support
Competing Interests: The authors have declared that no 
competing interests
Open Access: This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0)
Objective
Deep brain stimulation (DBS), which replaces 
thalamotomy, is a safe treatment method used for the 
treatment of Parkinson’s disease, tremor, dystonia, 
and some psychiatric disorders. As in almost every 
implantation surgery, DBS also has some specific 
complications [1], [2].
The most common complications of DBS surgery 
are hardware complications. Among these hardware 
infections and surgery area, erosions have special 
conditions [3], [4]. Some authors evaluate wound erosions 
as a complication independent from infection, while some 
others associate it with infection [5], [6], [7]. Due to this 
difference, infection rates have been reported between 
0% and 23% in the DBS series [7], [8], [9], [10], [11].
In the treatment of hardware infections, system 
removal is being considered in cases not responding 
to antibiotherapy [12], [13]. Temel et al. reported that 
antibiotherapy achieves up to 50% success in hardware 
infections, and system removal can control infection more 
effectively [14]. It becomes more challenging to reach a 
solution with medical treatment in the presence of persistent 
wound erosion associated with hardware infection, and 
sometimes, there is a need for wound revision. And finally, 
the process may end with system removal. However, 
this is an important problem, especially for patients who 
have significant benefits from DBS implantation, and the 
removal of the system can lead to depressive disorders [4].
In this study, we would like to discuss different 
aspects of hardware infections and contribute to the literature 
by presenting our treatment methods on four patients.
Materials and Methods
This study was carried out in Dokuz Eylül 
University Medical Faculty Hospital Neurosurgery 
Clinic. Four DBS cases were included in the study and 
a retrospective study was performed.
Bilateral subthalamic nucleus (STN-DBS) was 
performed in four patients due to Parkinson’s Disease. 
The electrodes were supplied from left postauricular 
area and placed on neurostimulator subclavicular area. 
The lead was removed from the left postauricular region. 
The neurostimulator was implanted in the subclavicular 
area. The same medical device brand was used for all 
cases, and there were no pre-operative complications.
Patients had not hypertension or any other 
comorbidities such as cancer. Only one patient had 
diabetes mellitus (Table 1).
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Results
Case – 1
A 53-year-old female patient with Parkinson’s 
Disease was implanted DBS to bilateral STN. She 
was suffering from diabetes mellitus and was using 
oral antidiabetic. In the post-operative follow-up, 
it was observed that the patient had a significant 
benefit and that she started performing her old habit 
of knitting. In the post-operative 3rd month, there was 
surgical site erosion on the left frontal incision, and 
the lead was protruded from skin (Figure 1). Hence, 
IV antibiotherapy and surgical site revision were 
performed to the patient, and the lead was transported 
to the subcutaneous tissue. In the post-operative 13th 
month (Figure 2), surgical site erosion was observed 
on the left postauricular incision, and the lead was 
protruded from skin, and there was liquid discharge on 
the right frontal side. Pseudomonas aeruginosa growth 
was determined in the sample which taken from wound 
discharge. Removing of DBS system was offered to 
the patient, but she did not accept the offer due to high 
benefits she got from the device, and her condition 
was good. On this, she received IV antibiotherapy, 
and then, surgical site revision was performed, and 
the lead was transported to the subcutaneous tissue 
again. In the post-operative 14th month, the patient 
was followed up with IV antibiotics on the development 
of purulent discharge on the postauricular region. In 
the post-operative 16th month, wound site revision 
was performed by taking the leads from postauricular 
region to the suboccipital fascia. In the post-operative 
18th month, surgical site erosion was observed on 
the left postauricular incision, and the lead was 
protruded from the skin. For that reason, wound site 
revision was performed. In the post-operative 20th 
month, neurostimulator on the left supraclavicular 
region was removed due to wound site erosion. Left 
supraclavicular region wound was debrided, the 
leads were transported right postauricular region, and 
neurostimulator was placed to the right supraclavicular 
region. Due to the right supraclavicular region erosion 
and protrusion of neurostimulator, DBS system was 
removed. During the management of the process, it 
was cooperated with the Plastic Surgery and Infectious 
Diseases departments.
Figure 1: Surgical site erosion in left frontal region and protruded lead 
from skin
Figure 2: Surgical site erosion in left postauricular region and 
protruded lead from 
Table 1: Features of cases
Features Case – 1 Case – 2 Case – 3 Case – 4
Age 53 62 64 61
Gender F F M M
Disease PD PD PD PH
Surgery Bilateral STN Bilateral STN Bilateral STN Bilateral STN
Beginning of infection 3rd month 4th month 1st month 3rd month
Number of wound site revision 6 2 - 1
Pathogen Pseudomonas aeruginosa - - Coagulase negative Staphylacoccus
Infection region Extension cables + PG Extension lead PG Extension lead
Therapy Surgery + antibiotherapy Surgery+antibiotherapy Puncture+ antibiotherapy Surgery + antibiotherapy
Antibiotics Cefepime + Ciprofloxacin Ampicillin and Sulbactam Ampicillin and Sulbactam Ampicillin and Sulbactam + Ciprofloxacin
Explantation of system Yes No No No
*PD: Parkinson disease, STN: Subthalamic nucleus, PG: Pulse generator, STN: Subthalamic nuclei.
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During this process, clinical findings of 
widespread or central nervous system infection were 
never observed. Laboratory values were within normal 
values, and there was no encephalitis sign in radiological 
studies. The patient did not allow removal of DBS 
system until the 22nd month of the operation despite all 
surgical site revisions and long-term hospitalizations for 
IV antibiotherapy.
Case – 2
A 62-year-old female patient with Parkinson’s 
disease was implanted DBS to bilateral STN. In the 
post-operative 4th month, there was surgical site erosion 
on the left postauricular incision, and the lead was 
protruded from the skin. Hence, IV antibiotherapy and 
surgical site revision were performed on the patient, and 
the lead was transported to the subcutaneous tissue. No 
agent was determined in the sample which was taken 
from the wound. Clinical findings and laboratory values 
of widespread or central nervous system infection were 
never observed. The patient who completed the 1st year 
of her operation is followed up as an outpatient without 
any problem.
Case – 3
A 64-year-old male patient with Parkinson’s 
disease was implanted DBS to bilateral STN. In the 
post-operative 1st month, swelling and erythema 
occurred in the subclavicular region. The swelling was 
drained (50cc) with a puncture using USG guidance. 
Microbiologic and empirical antibiotherapy were 
started. No microbiological agent was determined in 
the sample. The patient who had not repeated swelling 
after the treatment has been followed as outpatient.
Case – 4
A 61-year-old male patient with Parkinson’s 
disease was implanted DBS to bilateral STN. In the 
post-operative 3rd month, there was surgical site 
erosion on the left postauricular incision, and the lead 
was protruded from the skin (Figure 3). Coagulase-
negative staphylococcus was detected in the patient’s 
wound culture, and IV antibiotherapy was started. The 
patient, whose wound erosion was treated, is followed 
up as outpatient without any problem.
Discussion
As the number of the centers applying 
DBS implantation increases, the research papers 
concerning device-related infections start to take part 
in the literature. Tolleson et al. have taken into account 
the presence of epidermal erosions and infections 
regarding post-operative first 30 days and have found 
that previous presence of scalp erosion, the longer 
duration of the operation, and the presence of more 
people in the operation room is among the risk factors 
of a delayed infection [10]. In another study, the young 
age is described as a risk factor for the development 
of infection [15]. Immunity suppressing illnesses are 
potential risk factors for device-related infections [16]. In 
studies, no relation was found between the development 
of the infection and demographical data of the patients 
and indications of DBS implantation [4], [12], [17].
Kim et al. determined infection ratio as 7% 
in series that included 169 cases with Parkinson’s 
disease and implanted DBS. 75% of infections 
occurred during the first 3 months after operation. 
According to study results, as surgical profilaxy 1st 
generation cephalosporins were offered in 6 days after 
the operation due to their Gram-positive effect [18]. In 
our study, 75% of the infections occurred in the first 3 
months after DBS, and ampicillin/sulbactam profilaxy 
was applied during the first 10 days.
In our study, Pseudomonas was isolated in 
one female patient, and no cause was identified in 
other two. In a study with wider population, the most 
common isolated cause among men was Coagulase-
negative staphyloccocus, and among women were 
Methicillin-Susceptible Staphylococcus aureus 
and P. aeruginosa [19]. The data did suggest that 
intrawound VP may help to reduce the SSI risk after 
Figure 3: Surgical site erosion in left postauricular region and 
protruded lead from skin
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DBS implantation [3]. However, in this study, Gram-
positive bacteria were the most common pathogens 
(75%). Infection after DBS surgery was associated 
with short-term use of prophylactic antibiotics therapy. 
The antibiotherapy is given according to the isolated 
organism; and in our cases, 6–8 weeks of antibiotherapy 
was given. Removal of the DBS system also appears 
to be another treatment option with antibiotherapy. 
Patients benefited from the implantation do not consent 
for the system removal. Removal of the implantation and 
replantation at a future date for a complication which 
could be resolved through recent medical treatment 
options creates a huge impact on cost.
In three of our four cases, we found positive 
results with wound site revision and antibiotherapy. 
In our study, a resistant surgical site infection was 
developed in one patient. Although she received a long-
term antibiotic treatment and had six operations for 
surgical wound revision, she did not consent for device 
removal given that she significantly benefited from DBS. 
Increased incidence of wound complications in surgical 
patients with diabetes mellitus is a well-known condition. 
It can be thought that diabetes disease contributes to 
the negativities in this patient. Despite all studies, it 
was not clearly defined why some patients experience 
DBS-related infections and erosions on surgical site, 
while some others do not. In our opinion, the quality 
and thickness of scalp take a role in the development 
of surgical site erosion and device-related infections. In 
patients with poor scalp quality and thickness placing 
the microcatheter beneath, the galea and fascia could 
be considered. All patients were shaved before surgery. 
We believe that this application is effective in preventing 
infection as well as the use of antibiotics prophylaxis 
(ampicillin and sulbactam) before and after the surgery.
Conclusion
We consider that antibiotic therapy can be 
considered as an option in such situations before the 
removal of DBS system. In cases which are unresponsive 
to wound revision and have long-term antibiotherapy 
and/or developed central nervous system infection, we 
consider that removal of DBS system may be a right choice. 
New multicentral studies are needed for therapeutic 
protocols, improving new perspectives of infections of 
DBS implantations, and surgical site erosions.
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